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Abstract
Background: Previous work has indicated that post-traumatic stress disorder (PTSD) symptoms, measured by the
Clinician-Administered PTSD Scale (CAPS) within 60 days of trauma exposure, can reliably produce likelihood
estimates of chronic PTSD among trauma survivors admitted to acute care centers. Administering the CAPS is
burdensome, requires skilled professionals, and relies on symptoms that are not fully expressed upon acute care
admission. Predicting chronic PTSD from peritraumatic responses, which are obtainable upon acute care admission,
has yielded conflicting results, hence the rationale for a stepwise screening-and-prediction practice. This work
explores the ability of peritraumatic responses to produce risk likelihood estimates of early CAPS-based PTSD
symptoms indicative of chronic PTSD risk. It specifically evaluates the Peritraumatic Dissociative Experiences
Questionnaire (PDEQ) as a risk-likelihood estimator.
Methods: We used individual participant data (IPD) from five acute care studies that used both the PDEQ and the
CAPS (n = 647). Logistic regression calculated the probability of having CAPS scores ≥ 40 between 30 and 60 days
after trauma exposure across the range of initial PDEQ scores, and evaluated the added contribution of age, sex,
trauma type, and prior trauma exposure. Brier scores, area under the receiver-operating characteristic curve (AUC),
and the mean slope of the calibration line evaluated the accuracy and precision of the predicted probabilities.
Results: Twenty percent of the sample had CAPS ≥ 40. PDEQ severity significantly predicted having CAPS ≥ 40
symptoms (p < 0.001). Incremental PDEQ scores produced a reliable estimator of CAPS ≥ 40 likelihood. An
individual risk estimation tool incorporating PDEQ and other significant risk indicators is provided.
Conclusion: Peritraumatic reactions, measured here by the PDEQ, can reliably quantify the likelihood of acute PTSD
symptoms predictive of chronic PTSD and requiring clinical attention. Using them as a screener in a stepwise
chronic PTSD prediction strategy may reduce the burden of later CAPS-based assessments. Other peritraumatic
metrics may perform similarly and their use requires similar validation.
Trial registration: Jerusalem Trauma Outreach and Prevention Study (J-TOPS): NCT00146900.
Keywords: Emergency care admissions, Post-traumatic stress disorder, Peritraumatic symptoms, Sequential
prediction, Mega-analysis
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Background
Traumatic injury is common in the general population [1].
Worldwide, 56.2 million individuals sustain injuries that
require hospital admission per year [2]. In the United States
alone, emergency departments (EDs) treat 39 million injury
survivors per year, comprising 28% of all annual ED visits
[3]. Traumatic injury can be a significant precipitating
event for developing posttraumatic stress disorder (PTSD;
e.g. [4–7],), which, in its chronic form, is tenacious and
debilitating [8, 9], and which early cognitive behavioral
interventions may efficiently mitigate [10–13].
ED admissions provide crucial points of contact with pa-
tients at risk of developing PTSD. The best-known metrics
for estimating chronic PTSD risk are early PTSD symp-
toms, as assessed by structured clinical interviews such as
the Clinician-Administered PTSD Scale (CAPS [14, 15];).
However, most PTSD symptoms (e.g., insomnia, avoidance,
social withdrawal) are not fully expressed during ED admis-
sion, and their reliable assessment using the CAPS requires
two to 4 weeks of symptom duration [16]. Using the CAPS
is additionally burdensome because it requires time, clinical
expertise, and re-contacting patients. For example, a large
outreach and prevention study that inclusively
screened 5000 consecutive ED admissions and clinic-
ally evaluated 750 deemed at risk for PTSD within a
month of trauma exposure [17] found that bringing
one survivor with acute PTSD to treatment required
6.09 h of structured telephone interviews and 5.09 h
of clinical, CAPS-based assessments.
Alternatively, the immediate reactions to traumatic
events, otherwise known as peritraumatic responses, are
fully expressed and measurable upon ED admission. Unfor-
tunately, measures of peritraumatic distress perform rather
poorly as predictors of chronic PTSD [18–20].
Peritraumatic responses may, however, better predict
early PTSD symptoms [21], previously shown to robustly
predict chronic PTSD [14]. As such, peritraumatic re-
sponses might be used to identify a subset of trauma survi-
vors likely to develop early PTSD symptoms indicative of
high chronic PTSD risk. This type of stepwise strategy can
reduce the burden of unselective early clinical assessment.
Similar stepwise screening-and-assessment approaches
regularly inform disease prevention in other medical fields
(e.g., mammography towards breast biopsy, stool blood to-
wards colonoscopy, effort test towards angiography).
Several short, self-administered instruments have been
used to assess peritraumatic reactions, such as the Peri-
traumatic Distress Inventory (PDI, a 13-item instrument
[22];) and the Peritraumatic Dissociative Experiences
Questionnaire (PDEQ, a 10-item instrument [23];). The
latter evaluates the occurrence, during or shortly after
trauma exposure, of dissociation symptoms (discontinuity
or disintegration of conscious awareness [24]) previously
associated with PTSD risk.
A prior study by our group used multinational longitu-
dinal data [14] to evaluate the efficiency of CAPS scores
obtained within 60 days of a traumatic event as an early
risk indicator of chronic PTSD. Within that work, an initial
CAPS score greater than 40 points (CAPS ≥ 40) was asso-
ciated with higher than average likelihood (> 11%) of devel-
oping chronic PTSD. Extending upon these results, this
study evaluates the efficiency of the PDEQ as an estimator
of the likelihood of expressing CAPS ≥ 40 30 to 60 days
after ED admission. As in our previous study, we pooled
together eligible studies’ item-level individual data and
opted to use a continuous risk-estimate approach, i.e., pro-
duce probability scores of CAPS ≥ 40 for each incremental
PDEQ score. We thereby deviated from the more fre-
quently used case classification approach, which produces
a threshold (cut-off score) of the predictor (herein the
PDEQ) that optimally classifies survivors into those with
or without the outcome of interest (herein CAPS ≥ 40).
Derived by a logistic regression, our risk estimate approach
additionally allowed us to incorporate the effect of several
known PTSD risk indicators (e.g., sex, prior trauma expo-
sure) in the model.
This work constitutes a mega-analysis, in which raw data
from participating studies are analyzed at the individual
level, rather than at the study-level, as in a meta-analysis.
After controlling for contributing studies’ heterogeneities,
as detailed below, this approach allows the pooled data to
be used as a larger, more diverse study sample.
Data for this work were drawn from the same ED-
based, multinational dataset of trauma survivors [25],
wherein the PDEQ had the widest availability of all peri-
traumatic measures. Participants were traumatic injury
survivors treated in EDs in the United States, the
Netherlands, and Israel. Peritraumatic dissociation was
measured shortly after ED treatments. CAPS symptoms
were measured 30 to 60 days after ED treatments.
Methods
Sources of data
Data for this work were obtained from the pooled dataset
of the International Consortium to Predict PTSD (ICPP).
Studies contributing to the ICPP had longitudinally evalu-
ated adult civilians who were treated in general hospital
EDs following traumatic injuries. Mechanisms of injury in-
cluded motor vehicle accidents, other non-interpersonal
accidents (e.g., falls, burns), and interpersonal harm (e.g.,
assault, sexual violence). Table 1 presents participating
individual studies’ characteristics. Extended information
on the ICPP’s design and data harmonization can be
found in Qi et al. (2018) [25].
Participants
Participants for this work were those included in five
ICPP studies [26–30] that sequentially administered the
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PDEQ [23] and the Clinician-Administered PTSD Scale
for DSM-IV (CAPS [15]); Table 1). Eligible studies’
participants (n = 647; Table 2) were included if they had
a PDEQ assessment within 30 days of trauma exposure
and a CAPS interview between 30 and 60 days after
trauma exposure. Participants included in this work did
differ from those not included (n = 1179) on age (p =
0.045, t1048 = 2.00), but neither on sex (p = 0.334), PDEQ
severity score (p = 0.179, t1052 = − 1.34), or prior trauma
history (p = 0.334). However, after application of the
Hoch-Bonferroni adjustment for multiple comparisons,
the p-value for age became non-significant (p = 0.179).
Confidence intervals are supplied to complement the
statistical tests.
Instruments
Because they were performed before the publication of
DSM-5, ICPP studies used the DSM-IV version of the
CAPS. The CAPS is a structured clinical interview that
evaluates the intensity and the frequency of 17 DSM-IV
PTSD symptom criteria on a scale of 0–4 (score range =
0–136). The CAPS was administered by trained clinicians
30 to 60 days after ED treatment, a time bracket within
which a DSM-IV diagnosis of Acute PTSD is warranted.
The CAPS has demonstrated excellent psychometric
properties, with interrater reliability for continuous CAPS
scores consistently exceeding .90 [31], and similarly high
test-retest reliability. Alpha scores for the CAPS range
from .80 to .90 across symptom clusters and the disorder
as a whole [31]. In our data, Cronbach’s alpha for the
intrusion, avoidance, and hyperarousal symptom clusters
were 0.91, 0.87, and 0.87, respectively. Additionally, Cron-
bach’s alpha was 0.94 for the 17 CAPS items together.
The PDEQ is a self-report questionnaire measuring
peritraumatic dissociation [23]. The instrument’s 10 items
are rated on a 5-point scale of 1 (“not at all”) to 5 (“ex-
tremely true”). Seven PDEQ items were consistently used
across the five participating studies: “Blanked out”, “Being
Table 1 Participating Studies’ Designs, Countries of Origin, Sample Sizes, and Sample Characteristics
Study Design Country Studies’ total
samples
Current Eligible
participantsa
Trauma Types among
participants (MVA, OA, IV)b
Irish et al., 2008 [26] Observation USA 406 144 100, 0, 0%
Mouthaan et al., 2013 [27] Observation The Netherlands 852 250 62.00, 34.80, 3.20%
Shalev et al., 2000 [28] Observation Israel 235 123 86.18, 6.50, 7.32%
Shalev et al., 2008 [29] Observation Israel 279 88 80.23, 4.65, 15.12%
van Zuiden et al., 2017 [30] Intervention The Netherlands 54 42 69.05, 21.43, 9.52%
aReflects those meeting inclusion criteria specified under method/participants
bMVA motor vehicle accident, OA other accident, IV interpersonal violence
Table 2 Sample demographics by CAPS score at 30–60 days post-trauma
Variable CAPS IV < 40 CAPS IV ≥ 40 Test Statistic p Total Sample
Participants (N (%)) 517 (79.91%) 130 (20.09%) 647
PDEQ Total Score (Mean; (SD); [95%CI]) 15.15 (6.07) = [14.62, 15.67] 21.79 (6.53) [20.66, 22.93] −10.51 df = 189 0.001a 16.48 (6.71) [15.97, 17.00]
Age (Mean; (SD); [95%CI]) 38.91 (15.80) [37.55, 40.28] 34.49 (13.02) [32.23, 36.75] 3.31 df = 234 0.001a 38.02 (15.38) [36.84, 39.21]
Sex N/A 0.001b
Female [N(%)] 208 (40.23%) 75 (57.69%) 283 (43.74%)
Male [N(%)] 309 (59.77%) 55 (42.31%)
Prior trauma c N/A 0.002 b
None [N (%)] 62 (12.23%) 10 (7.75%) 72 (11.32%)
Non-Interpersonal [N (%)] 208 (41.03%) 36 (27.91%) 244 (38.36%)
Interpersonal [N (%)] 237 (46.75%) 83 (64.34%) 320 (50.31%)
Current Trauma d N/A 0.001 b
MVA [N(%)] 400 (77.52%) 103 (79.84%) 503 (77.98%)
Non-MVA [N(%)] 97 (18.80%) 11 (8.53%) 108 (16.74%)
Interpersonal violence [N(%)] 19 (3.68%) 15 (11.63%) 34 (5.27%)
Abbreviations: CAPS clinician administered PTSD Scale for DSM IV, PDEQ peri-traumatic dissociation questionnaire, MVA motor vehicle accidents, df degrees of
freedom, N/A not applicable
a Welch’s t-test
b Fisher’s test
c Data on prior trauma history were missing for 12 participants
d Data on current trauma were missing for 2 participants
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on automatic pilot”, “Sense of time changed”, “What hap-
pened seemed unreal”, “Floating above the scene”, “Feeling
disconnected from the body”, and “Things happened with-
out awareness”, yielding a 7–35 point score range. The
10-item and revised 8-item PDEQ have both demon-
strated good internal consistency, with alpha scores ran-
ging from .81 to .85 [22, 32], as well as good test-retest
reliability (r = .85, p < .01) on the 8-item PDEQ [32]. In
our sample, Cronbach’s alpha for the PDEQ was 0.80.
Additionally, sex, age, current trauma type (motor ve-
hicle accident, other accident, or interpersonal violence),
and lifetime trauma history (no prior trauma, prior non-
interpersonal trauma, and prior interpersonal trauma)
were evaluated.
Data analysis
Main outcome measure
The categorical outcome measure for this work was a
CAPS total score ≥ 40 points, reflective of moderate
PTSD severity and previously associated with ≥11%
likelihood of PTSD 9 to 15 months after trauma
exposure [14].
To compare participants with CAPS ≥ 40 scores with
those below that threshold, we used Welch’s t-test for con-
tinuous variables and Fisher’s test for categorical variables.
A logistic regression analysis assessed the impact of co-
variates on the association between PDEQ total score and
CAPS score ≥ 40. Complete-case analysis was used in
instances of missing data.
To assess whether pooling of individuals from different
study sites was appropriate for this analysis, the I2, a meas-
ure of unexplained heterogeneity between effect sizes,
assessed heterogeneity of study-specific log odds ratios de-
rived from logistic regression in study-stratified models. As
an additional measure of heterogeneity, a test of the homo-
geneity of the effect sizes was conducted via the Q statistic.
Logistic regression was used to derive the probability of
a CAPS score ≥ 40 given the PDEQ total score. Follow-
ing Debray et al. (2013) [33], both stacked models and
stratified intercept models were derived, where a stacked
intercept model pools individuals without accounting for
data source, and a stratified intercept model includes a
term for data source. A random effects model was not
used due to the low number of studies.
The significance of logistic regression coefficients was
tested via Z-test at the 5% level of significance. Predicted
probabilities were calculated through conversion of the pre-
dicted log odds of the outcome, and confidence intervals
were calculated.
The accuracy of the predicted probabilities was
assessed using the Brier score, which is a number be-
tween 0 and 1, with a lower score indicating a stronger
predictive model [34]. Additionally, the Brier Skill Score
was also used, which ranges from 0 to 1, with a number
closer to 1 indicating a stronger predictive model [34].
The Brier Skill Score calculates the model’s improve-
ment in Brier Score relative to a naïve model. The area
under the receiver-operating characteristic curve (AUC)
was calculated to assess the ability of the PDEQ to dis-
criminate between cases (CAPS ≥ 40) and non-cases by
using the predicted probabilities from the model com-
pared to the observed outcomes. Calibration slope was
calculated through bootstrap resampling of the study
with 1000 repetitions to measure the accuracy of the
predicted probabilities, with a slope closer to 1 indicat-
ing more accurate predicted probabilities and slopes
greater than 1 reflecting underfitting of probabilities and
slopes less than 1 representing overfitting of predicted
probabilities. For the calibration slope calculation, ob-
served outcomes were regressed on predicted logits for
each iteration of the bootstrap via logistic regression and
the beta for the predicted logits averaged across repeti-
tions. Ridge penalizations and transformations of PDEQ
score were considered, if underfitting and overfitting
were found by examining calibration slope and plots.
The strength of the predicted probabilities and the dis-
criminatory power of the final model were further
assessed in each study separately in order to assess the
validity of the model in different samples by calculating
the AUC and Brier Skill Score for each study. Addition-
ally, to assess the increase in predictive power by inclu-
sion of the PDEQ relative to demographic and trauma
variables alone, DeLong’s test was performed between
the adjusted PDEQ model and the demographic and
trauma variable alone model [35].
Sensitivity analyses
The effect of PDEQ assessment timing (number of days
from ED treatment) on the association between PDEQ
and CAPS ≥ 40 score was evaluated via the incorporation
of an interaction term between PDEQ score and the days
since trauma for the PDEQ assessment. Likewise, the ef-
fect of CAPS assessment timing (days from ED treatment)
on the association between PDEQ and CAPS ≥ 40 was
evaluated via the incorporation of an interaction term be-
tween PDEQ score and the days since trauma of the CAPS
assessment. A model where the first CAPS assessment
was used, regardless of date, to include more of the sample
was called the unrestricted model.
All significance tests were at the 5% level of significance,
and all confidence intervals were at the 95% level of
confidence. All analyses were conducted with R version
3.4.0 [36].
Results
Descriptive statistics
Table 2 presents the sample characteristics. There were
647 subjects from 5 studies. One hundred and thirty
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participants (20.09%; subsequently referred to as “cases”)
had a CAPS ≥ 40 in the 30–60 days after trauma time
period. Cases had significantly higher PDEQ scores than
non-cases (p < 0.001, t189 = − 10.51) and were younger (p =
0.001, t234 = 3.31). Cases were more likely to have interper-
sonal trauma as their most recent trauma (p < 0.001) and
have experienced prior interpersonal trauma (p = 0.002).
Women had 2.02 (36.05% vs 17.79, 95% CI = [1.35, 3.05])
times the odds of having a CAPS score over 40 than men
(p < 0.001). Eleven participants were missing data on prior
trauma history and two participants were missing data on
current trauma type. Confidence intervals are supplied as
an alternative means of assessing group differences.
Assessing study-dependent heterogeneity and
appropriateness of pooling
The I2 was 56.67%, indicating moderate heterogeneity in
regression coefficients. Q Test statistic for heterogeneity
was 8.92 with 4 degrees of freedom (p = 0.063), which
suggests that there is insufficient evidence to suggest
that effect sizes are heterogeneous in a manner that is
statistically significant. Odds measuring the relative in-
crease in log odds of having a CAPS score over 40 for a
one unit increase in PDEQ score and 95% confidence in-
tervals for each of the studies were as follows (studies’
references in parentheses): b = 0.08 [0.01, 0.16] [26], b =
0.13 [0.08, 0.19] [27], b = 0.24 [0.15, 0.33] [28], b = 0.18
[0.09, 0.27] [29], and b = 0.25 [0.05, 0.46] [30]. Due to
the moderate amount of heterogeneity between studies,
pooling the studies for analysis was deemed appro-
priate. See Fig. 1.
Prediction of CAPS score over 40 by PDEQ – comparing
models (Table 3)
All models are without transformations and ridge
penalizations.
The stacked model with PDEQ only (Table 3, column 2)
had an intercept of − 4.22 and a PDEQ coefficient of 0.15
(SE = 0.02, p < 0.001), meaning that a one unit increase in
PDEQ score corresponds to a 1.17 (95% CI = [1.13, 1.21])
fold increase in the odds of having a CAPS score over 40.
The stacked model adjusted for age, sex, trauma type,
and prior trauma history (Table 3, column 3): The model
intercept was − 4.64, and the coefficient for the PDEQ was
0.16 (SE = 0.02, p < 0.001), meaning that a one unit in-
crease in PDEQ score corresponds to a 1.17 (Beta = 0.02,
95% CI = [1.13, 1.22]) fold increase in the risk of having a
CAPS score over 40. Additionally, if the trauma was a
non-interpersonal, non-motor vehicle accident, the odds
of having a CAPS score over 40 were reduced by 57% rela-
tive to motor vehicle accidents (Beta = − 0.83, OR = 0.43,
95% CI = [0.20, 0.93], p = 0.031). Also, prior interpersonal
trauma was significant in increasing the odds of having a
CAPS score over 40 by a factor of 2.75 relative to no prior
trauma (Beta = 1.01, 95% CI = [1.21, 6.28], p = 0.016).
Women were found to have odds of having a CAPS score
over 40 that were 70% greater than men (Beta = 0.53,
OR = 1.70, 95% CI = [1.09, 2.67], p = 0.019). All other
variables were statistically non-significant (p > 0.05).
The stratified model with PDEQ only (Table 3, column
4) had an intercept of − 4.32 and a PDEQ coefficient of
0.16 (SE = 0.02, p < 0.001), meaning that a one-unit
increase in PDEQ score corresponds with a 1.17 (95% CI =
[1.13, 1.21]) fold increase in risk of having a CAPS score
over 40, when accounting for study-source.
The stratified model adjusted for age, sex, trauma type,
and prior trauma history (Table 3, column 5) had an inter-
cept of − 4.90, and the coefficient for the PDEQ was 0.16
(SE = 0.02, p < 0.001), meaning that a one-unit increase in
PDEQ score corresponds to a 1.17 (95% CI = [1.13, 1.22])
fold increase in the risk of having a CAPS score over 40.
Prior interpersonal trauma was associated with an increase
in the risk of having a CAPS score over 40 by a factor of
2.58 relative to no prior trauma (Beta = 0.95, 95% CI =
[1.11, 5.99], p = 0.027). Additionally, if the trauma was an
incident of interpersonal violence, the odds of having a
CAPS score over 40 were increased by a factor of 2.36
relative to motor vehicle accidents (Beta = 0.86, 95% CI =
[1.01, 5.51], p = 0.048). Lastly, women had 1.68 times the
Fig. 1 Forest plot of log odds ratios between PDEQ Score and CAPS ≥ 40 for individual studies
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odds of having a CAPS score over 40 (Beta = 0.52, 95%
CI = [1.07, 2.64], p = 0.024). Neither age nor any of the
data sources were statistically significant (p > 0.05). See
Table 3.
Final model selection and validation
Based on AUC and Brier Skill Score, the stacked and ad-
justed model performed better than other models. Brier
Skill Scores ranged from 0.08 to 0.31. AUCs ranged from
0.73 to 0.85. The validation results indicate fair to good
discriminatory power, according to AUC, and weak to
moderate improvements in predicted probabilities rela-
tive to a naïve model, according to Brier Skill Score.
Table 3 additionally shows a model featuring only demo-
graphic and trauma variables. The stacked and adjusted
PDEQ model has a higher AUC (0.81) than the demo-
graphic and trauma variable alone model (0.69).
DeLong’s test illustrates that the stacked and adjusted
PDEQ model has a statistically significantly different
AUC than the demographic and trauma variable only
model (Z = − 4.94, p < 0.001).
Likelihood estimate calculation
CAPS ≥ 40 (high risk) likelihood estimates based on the
stacked and adjusted model are provided as a web-based
risk calculator on https://wvdmei.shinyapps.io/results_
lookup/. This calculator reports and visualizes individual
acute PTSD likelihood estimates based on either the
PDEQ alone, or the PDEQ plus sex, age, mechanism of
injury, and lifetime trauma exposure. Table 4 provides
predicted probabilities and 95% confidence intervals for
different covariate values of the regression model
stacked and adjusted for covariates.
Sensitivity analyses
Influence of assessment timing
The median time from ED treatment to the first PDEQ
administration was 9 days (25th percentile = 3.50, 75th
percentile = 17.50, Range = 0–30). Median time to the
first CAPS administration between 30 to 60 days was 42
days (25th percentile = 35, 75th percentile = 49.00,
Range = 31–60). There was insufficient evidence to sug-
gest that timing of the PDEQ moderated the relationship
between PDEQ score and a CAPS ≥ 40 (b = − 0.001, SE =
0.002, p = 0.610) based on a test of the interaction term.
However, the data did suggest that later timing of the
CAPS assessment moderated the relationship between
PDEQ score and CAPS ≥ 40 by decreasing the size of
the odds ratio for PDEQ score (b = − 0.01, SE = − 0.004,
p = 0.019), via a test of the interaction term.
Discussion
Our results demonstrate that peritraumatic reactions,
evaluated here by the PDEQ, can be used to produce a
risk estimate of acute PTSD (CAPS ≥ 40) symptoms in-
dicative of above-average risk of chronic PTSD. The risk
model was shown to have fair-to-good performance
when validated in the individual studies, thereby exhibit-
ing utility in heterogeneous populations. Importantly,
the CAPS ≥ 40 subgroup concerned about one fifth
(20.09%) of the total sample, illustrating the ability of a
peritraumatic screening to significantly reduce the num-
ber of structured clinical evaluations (i.e., CAPS assess-
ments) administered within 30 to 60 days required to
quantify survivors’ risk of chronic PTSD. The model
used in this work additionally documented the effect of
several covariates (sex, age, trauma type and lifetime
trauma exposure) on PDEQ-based risk estimation.
Extending previous longitudinal studies that used
structured clinical interviews to predict downstream
PTSD [14, 38], our results demonstrate the utility of
using a short self-report measure to produce a likelihood
estimate of early CAPS scores, themselves predictive of
chronic PTSD. Self-report measures, such as the PDEQ,
may be useful in ED settings given their minimal burden
on personnel and resources. They therefore present
plausible candidates for a stepwise, screen-and-assess
approach to PTSD risk assessment, capable of guiding
early prevention. In this work specifically, the 7-item
PDEQ represents a particularly short screening tool that
could be well-suited for time-sensitive ED assessment.
This model introduces to ED psychiatry a nomogram
approach extensively used in other areas of medicine,
allowing physicians to assign a risk likelihood percentage
to each person at risk given a set of predictors. The
model also innovatively combines several risk factors in
its individual likelihood estimates, demonstrating the
powerful effect of quickly measurable covariates on
PTSD risk.
In this work, given the multiplicity of predictors and in-
dividual risk estimates, we do not recommend an a priori
cut-off score for follow-up assessment. Within this ap-
proach, clinicians and service providers have the flexibility
to determine follow-up care based on hospital resources
and patient-practitioner clinical decision-making. Like-
wise, the predictive models with and without covariates
allow emergency personnel to use either a longer (but
more illustrative) or more efficient screening tool based
on situational needs, each performing similarly well.
This study is not without weaknesses worthy of notice.
First, PDEQ assessments in this work were taken at a
median of 9 days from the traumatic event and not dur-
ing ED treatment. However, the finding that the timing
of PDEQ measurement (within the 0 to 30 day time
bracket) did not modify the instrument’s performance as
a risk estimator reduces the likelihood of a major differ-
ence in predictive accuracy between ED and subsequent
assessment timing.
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Second, this work considered one of several metrics of
peritraumatic reactions, the PDEQ, and thereby might have
preferentially captured the effect of peritraumatic dissoci-
ation (i.e., derealization and depersonalization) rather than
other immediate reactions to trauma exposure. Indeed, pre-
vious work suggests that peritraumatic dissociation and peri-
traumatic distress (as captured by the PDI) independently
contribute to downstream PTSD [22]. Having tested the
PDEQ alone, we relate to this work as a “proof of concept”
study. The extent to which other peritraumatic measure-
ments can be similarly employed is yet to be determined.
A third apparent limitation is that, once the covariates
are included in the predictive model, the predicted prob-
abilities are characterized by wide confidence intervals in
some cases, thereby at times reducing the model’s preci-
sion. However, as can be seen in Table 4, the predicted
probabilities are significantly influenced by covariates such
as sex, mechanism of injury, and previous trauma exposure.
For example, a PDEQ score of 20 can result in predicted
probabilities ranging from 5.29 (CI = [1.95, 13.6]) for a male
with current non-interpersonal trauma and no history prior
trauma exposure, to 57.29 (CI = 36.11, 76.11) for a female
with current interpersonal trauma and prior history inter-
personal trauma exposure, and non-overlapping CIs. Thus,
while the model employing the PDEQ alone has more pre-
cision (i.e., less variance) than the model that included co-
variates, its predictions are, importantly, biased by ignoring
their effects. As such, while potentially decreasing the preci-
sion of the model, the covariates examined here reduce the
prediction bias of the PDEQ-only model, and provided
critical information about moderators of acute PTSD risk
estimates upon ED admission. Lastly, the calibration slope
indicates that the PDEQ alone model is slightly under-
fitted. This number suggests that while the improvements
in Brier Skill Score and AUC are modest in the adjusted
model, the model is also better able to capture the under-
lying structure of the data than the PDEQ alone model.
Fourth, PTSD diagnoses in this study were based on
DSM-IV diagnostic criteria rather than the currently
used DSM-5. The extent to which the predictive model
performs equally well in predicting DSM-5 acute PTSD
is an inquiry worthy of scientific rigor.
Lastly, several potential confounders of PDEQ predic-
tion, such as race, income, and education, as well as
other known PTSD risk indicators, such as ED heart rate
[39], head injury [40], general distress, or ED pain levels
[37] were not included in the work, and their eventual
effects remain untested.
Our results require replications and external validations
to be safely generalized. However, in this work, the
stacked model and the stratified model performed equally
well across participating studies, providing preliminary
evidence that the generic, stacked model used in this study
could be applied to diverse acute care settings.
Conclusion
This work suggests that instruments measuring an initial
reaction to trauma exposure, i.e., peritraumatic and ED
distress, could be used to screen individuals in need of
subsequent assessment of emerging and properly termed
post-traumatic symptoms that are highly predictive of
longer-term PTSD. It thereby informs the rationale and
suggests the potential cost-effectiveness of staged, se-
quential assessment of PTSD risk in recent survivors
seen in acute care centers.
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